Home » Tenders » Americas » Brazil » Regular Acquisition of Medicines Belonging to Group 09.R.03.A (Adrenergic Inhalants),... Tender

Regular Acquisition of Medicines Belonging to Group 09.R.03.A (Adrenergic Inhalants),... Tender

Download Documents

FEDERAL DISTRICT GOVERNMENT - GDF has floated a tender for Regular Acquisition of Medicines Belonging to Group 09.R.03.A (Adrenergic Inhalants), Group: 09.R.03.D (Other Systemic Medicines for Obstructive Airway Disease), Group: 09.R.03.A ( ...19981D172c851bd4e8a1788d5726c2d3. The project location is Brazil and the tender is closing on 04 Apr 2024. The tender notice number is 90056/2024, while the TOT Ref Number is 99231931. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Brazil

Summary : Regular Acquisition of Medicines Belonging to Group 09.R.03.A (Adrenergic Inhalants), Group: 09.R.03.D (Other Systemic Medicines for Obstructive Airway Disease), Group: 09.R.03.A ( ...19981D172c851bd4e8a1788d5726c2d3

Deadline : 04 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99231931

Document Ref. No. : 90056/2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Object: Electronic Auction - Regular acquisition of medicines belonging to Group 09.R.03.A (ADRENERGIC INHALANTS), Group: 09.R.03.D (OTHER SYSTEMIC MEDICINES FOR OBSTRUCTIVE AIRWAY DISEASE), Group: 09.R .03.A (ADRENERGIC INHALANTS), Group: 09.R.03.D (OTHER SYSTEMIC DRUGS19981d172c851bd4e8a1788d5726c2d3S FOR OBSTRUCTIVE AIRWAY DISEASE), Group: 09.R.07.A (OTHER PRODUCTS FOR THE RESPIRATORY SYSTEM), in SRP, to meet SES DF, according to specifications and quantities contained in Annex I of the Notice.

Code of UASG: 926119

Notice from: 03/22/2024 from 08:00 to 12:00 and 13:0019981d172c851bd4e8a1788d5726c2d3At 17:00 hs

Delivery of the proposal: from 03/22/2024 to 08:00

Formoterol Fumarato, composition associated with budsonide, concentration 12 mcg 400mcg/dose, Pharmaceutical form inhaler capsule, additional characteristics with inhaler vial

Quantity: 2137680

FORMOTEROL FUMARATE, COMPOSITION19981d172c851bd4e8a1788d5726c2d3ASSOCIATED WITH BUDESONIDE, CONCENTRATION 12 MCG 400MCG/DOSE, PHARMACEUTICAL FORM CAPSULE INHALER POWDER, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE

Quantity: 712560

FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH BUDESONIDE, CONCENTRATION 6 MCG 200 MCG/DOSE, PHARMACEUTICAL FORM CAPSULE INHALER POWDER, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE

Quantity: 135695

FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH BUDESONIDE, CONCENTRATION 6 MCG 200 MCG/DOSE, PHARMACEUTICAL FORM CAPSULE INHALER POWDER, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE

Quantity: 45232

FORMOTEROL FUMARATE, CONCENTRATION12 MCG, PHARMACEUTICAL FORM CAPSULE INHALER POWDER, ADDITIONAL CHARACTERISTICS WITH INHALER BOTTLE

Quantity: 39560

GLYCOPYRRONUM, SALT BROMIDE COMPOSITION, CONCENTRATION 63 MCG, PHARMACEUTICAL FORMCAPSULE POWDER FOR INHALATION, ADDITIONAL WITH INHALER

Quantity: 3920 23

GLYCOPYRRONIUM, SALT BROMIDE COMPOSITION, WONCENTRATION 63 MCG, PHARMACEUTICAL FORMPOWDER CAPSULE FOR INHALATION, ADDITIONAL WITH INHALER

Quantity: 130675

SALMETEROL XINAFOATE, C...